Lad TE - Search Results

1

A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.

Vokes EE, Ansari RH, Masters GA, Hoffman PC, Klepsch A, Ratain MJ, Sciortino DF, Lad TE, Krauss S, Fishkin PA, Golomb HM. Vokes EE, et al. Among authors: lad te. Ann Oncol. 1998 Oct;9(10):1085-90. doi: 10.1023/a:1008432729754. Ann Oncol. 1998. PMID: 9834820 Free article. Clinical Trial.

2

Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies.

Minami H, Lad TE, Nicholas MK, Vokes EE, Ratain MJ. Minami H, et al. Among authors: lad te. Clin Cancer Res. 1999 Jun;5(6):1325-30. Clin Cancer Res. 1999. PMID: 10389915 Clinical Trial.

3

Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer.

Lad T, Rosen F, Sciortino D, Brockstein B, Keubler JP, Arietta R, Vokes E. Lad T, et al. Invest New Drugs. 2000 Aug;18(3):261-3. doi: 10.1023/a:1006481924287. Invest New Drugs. 2000. PMID: 10958595 Clinical Trial.

4

Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.

Rosen F, Vokes EE, Lad T, Kies M, Wade J 3rd, Kilton LJ, Blough R, French S, Mullane M, Benson AB 3rd. Rosen F, et al. Invest New Drugs. 1995;13(3):249-52. doi: 10.1007/BF00873808. Invest New Drugs. 1995. PMID: 8729954 Clinical Trial.

5

Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.

Lad TE, Blough RR, Evrard M, Shevrin DP, Cobleigh MA, Johnson CM, Hange P. Lad TE, et al. Invest New Drugs. 1989 Jul;7(2-3):223-4. doi: 10.1007/BF00170862. Invest New Drugs. 1989. PMID: 2551841

6

Postsurgical adjuvant therapy in stages I, II, and IIIA non-small cell lung cancer.

Lad TE. Lad TE. Hematol Oncol Clin North Am. 1990 Dec;4(6):1111-9. Hematol Oncol Clin North Am. 1990. PMID: 1962778 Review.

7

Phase II trial of aminothiadiazole in advanced non-small cell lung cancer.

Shevrin DH, McGuire WP, Lanzotti V, Krauss S, Blough R, Cobleigh M, Johnson C, Lad T, Kukla L. Shevrin DH, et al. Cancer Treat Rep. 1986 Mar;70(3):417-8. Cancer Treat Rep. 1986. PMID: 3955556 No abstract available.

8

Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.

Rose C, Lad TE, Kilton LJ, Schor J, Rosen ST, Rossof AH, Blough RR, Johnson CM. Rose C, et al. Among authors: lad te. Invest New Drugs. 1990 Feb;8(1):97-9. doi: 10.1007/BF00216932. Invest New Drugs. 1990. PMID: 2160920 Clinical Trial.

9

Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance).

Sharma MR, Mehrotra S, Gray E, Wu K, Barry WT, Hudis C, Winer EP, Lyss AP, Toppmeyer DL, Moreno-Aspitia A, Lad TE, Velasco M, Overmoyer B, Rugo HS, Ratain MJ, Gobburu JV. Sharma MR, et al. Among authors: lad te. J Clin Pharmacol. 2020 Apr;60(4):444-452. doi: 10.1002/jcph.1559. Epub 2019 Dec 4. J Clin Pharmacol. 2020. PMID: 31802506 Free PMC article.

10

Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council Study.

Shevrin DH, Lad TE, Kilton LJ, Cobleigh MA, Blough RR, Weidner LL, Vogelzang NJ. Shevrin DH, et al. Among authors: lad te. Invest New Drugs. 1989 Jul;7(2-3):251-3. doi: 10.1007/BF00170869. Invest New Drugs. 1989. PMID: 2477345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters